1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Viscosupplementation Market, by Product
6.1. Introduction
6.2. Five Injection
6.3. Single Injection
6.4. Three Injection

7. Viscosupplementation Market, by Source
7.1. Introduction
7.2. Animal
7.3. Nonanimal

8. Viscosupplementation Market, by Application
8.1. Introduction
8.2. Hand Osteoarthritis
8.3. Hip Osteoarthritis
8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use
9.1. Introduction
9.2. Hospitals
9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. California Viscosupplementation Market

11. Florida Viscosupplementation Market

12. Illinois Viscosupplementation Market

13. New York Viscosupplementation Market

14. Ohio Viscosupplementation Market

15. Pennsylvania Viscosupplementation Market

16. Texas Viscosupplementation Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Alcon Vision LLC
18.2. Allergan, Inc.
18.3. Anika Therapeutics, Inc.
18.4. Bausch Health Companies Inc
18.5. Bioventus LLC
18.6. Chugai Pharmaceutical Co., Ltd.
18.7. Contipro A.S.
18.8. F. Hoffmann-La Roche AG
18.9. Ferring B.V.
18.10. Fidia Farmaceutici S.P.A.
18.11. Galderma Laboratories, L.P.
18.12. Johnson & Johnson Services, Inc
18.13. LG Life Sciences Ltd
18.14. Lifecore Biomedical, LLC
18.15. Mylan N.V.
18.16. OrthogenRx, Inc
18.17. Regen Lab SA
18.18. Salix Pharmaceuticals, Inc.
18.19. Sanofi S.A.
18.20. Seikagaku Corporation
18.21. Smith & Nephew Plc
18.22. Teva Pharmaceutical Industries Ltd
18.23. Zimmer Biomet

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES VISCOSUPPLEMENTATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES VISCOSUPPLEMENTATION MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2027
FIGURE 6. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2027
FIGURE 15. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 20. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2027
FIGURE 22. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2020 VS 2027 (%)
FIGURE 29. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2020 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2027
FIGURE 31. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX
FIGURE 36. UNITED STATES VISCOSUPPLEMENTATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 37. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES VISCOSUPPLEMENTATION MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES VISCOSUPPLEMENTATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET: SCORES
TABLE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET: BUSINESS STRATEGY
TABLE 19. UNITED STATES VISCOSUPPLEMENTATION MARKET: PRODUCT SATISFACTION
TABLE 20. UNITED STATES VISCOSUPPLEMENTATION MARKET: RANKING
TABLE 21. UNITED STATES VISCOSUPPLEMENTATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 22. UNITED STATES VISCOSUPPLEMENTATION MARKET: MERGER & ACQUISITION
TABLE 23. UNITED STATES VISCOSUPPLEMENTATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 24. UNITED STATES VISCOSUPPLEMENTATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 25. UNITED STATES VISCOSUPPLEMENTATION MARKET: INVESTMENT & FUNDING
TABLE 26. UNITED STATES VISCOSUPPLEMENTATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 27. UNITED STATES VISCOSUPPLEMENTATION MARKET: LICENSE & PRICING

Companies Mentioned

Alcon Vision LLC
Allergan, Inc.
Anika Therapeutics, Inc.
Bausch Health Companies Inc
Bioventus LLC
Chugai Pharmaceutical Co., Ltd.
Contipro A.S.
F. Hoffmann-La Roche AG
Ferring B.V.
Fidia Farmaceutici S.P.A.
Galderma Laboratories, L.P.
Johnson & Johnson Services, Inc
LG Life Sciences Ltd
Lifecore Biomedical, LLC
Mylan N.V.
OrthogenRx, Inc
Regen Lab SA
Salix Pharmaceuticals, Inc.
Sanofi S.A.
Seikagaku Corporation
Smith & Nephew Plc
Teva Pharmaceutical Industries Ltd
Zimmer Biomet